β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression

Endocrine therapies have been successfully used for breast cancer patients with estrogen receptor α (ERα) positive tumors, but ∼40% of patients relapse due to endocrine resistance. β-glucans are components of plant cell walls that have immunomodulatory and anticancer activity. The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: JAFAAR, ZAINAB M.T., LITCHFIELD, LACEY M., IVANOVA, MARGARITA M., RADDE, BRANDIE N., AL-RAYYAN, NUMAN, KLINGE, CAROLYN M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977804/
https://www.ncbi.nlm.nih.gov/pubmed/24534923
http://dx.doi.org/10.3892/ijo.2014.2294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977804/
https://www.ncbi.nlm.nih.gov/pubmed/24534923
http://dx.doi.org/10.3892/ijo.2014.2294

Ejemplares similares